PATENT CLAIM ANALYSIS

Application Number: 16111500
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "005900"]

Abstract:
The present system is directed in several embodiments to a method of administration of a therapeutic composition for treatment of seizures resulting from epilepsy and other seizure disorders. The method includes administering one or more therapeutic compositions comprising an effective amount of insulin directly to the subject patient's CNS, with no to minimal systemic exposure. Preferably, this method comprises administration of an effective amount of insulin to the upper third of a patient's nasal cavity, thereby bypassing the patient's blood-brain barrier and delivering the therapeutic composition directly to the patient's central nervous system.

Claim (Index 6):
The method of  claim 1 , wherein the at least an effective amount of insulin is in the range of 1\u00d710 \u22127  to 0.1 mg/kg.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 96.0
- Lexical Diversity: 1.63492
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14202932', '14679667', '15340160', '14040915', '13650344']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7946483201258129
- 35 USC 102 Novelty (BERT): 0.5082287003173062
- Combined Prediction Score: 0.7660063581449622
- Mean Citation Score: 297.697668
- Max Citation Score: 311.47104
- Similarity Product: 297.2461846102524

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test